Related references
Note: Only part of the references are listed.Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Erica J. Brenner et al.
GASTROENTEROLOGY (2020)
Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia
Xiaotan Dou et al.
ONCOLOGY LETTERS (2015)
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ
C Rousseaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters
FN Hussain et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
